The Clinical Efficacy of a Topical Selective EP2 Receptor Agonist Against Feline Glaucoma That Is Not Responsive to Conventional Anti‐Glaucoma Eyedrops
OMDI could be an additional therapeutic option for feline glaucoma that is unresponsive to conventional therapies. Administration of OMDI following the early diagnosis of glaucoma is recommended to maximize therapeutic efficacy.
Authors
- Jaesang Ahn (ORCID: https://orcid.org/0000-0002-4771-4700)
- Dajeong Jeong (ORCID: https://orcid.org/0000-0001-6129-2391)
Institutions
- Kim's Eye Hospital (KR)
- Onnuri Smile Eye Clinic (KR)
Publication Details
- Journal
- Veterinary Ophthalmology
- Published
- 2025-07-26
- DOI
- https://doi.org/10.1111/vop.70047
- Citations
- 1
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.71